10-K: Agape ATP Corp. Reports FY2025 Results, Revenue Up 15%

Agape ATP Corporation announced its fiscal year 2025 results, showing a 15.2% increase in revenue to $1.52 million, driven by growth in wellness and green energy segments, despite a net loss.

Summary

• Agape ATP Corporation reported a 15.2% increase in revenue for the fiscal year ended December 31, 2025, reaching $1,524,262, up from $1,322,747 in 2024.
• The company experienced a net loss of $2,307,607 for FY2025, a slight improvement from the $2,486,044 net loss in FY2024.
• Revenue growth was primarily driven by a significant increase in the wellness and wellbeing lifestyle segment (up 948.9%) and the green energy segment (up 226.7%).
• The network marketing business revenue decreased by 48.0%, and the complementary health therapies segment saw a 3.5% decrease in revenue.
• Operating expenses increased by 22.9% to $4,094,917, largely due to higher selling and general administrative expenses.
• The company's cash position decreased significantly, with cash and cash equivalents at $140,072 as of December 31, 2025, compared to $2,040,243 in the prior year.
• Net cash used in operating activities was $2,413,422, and investing activities used $23,001,049, primarily for advances for investment.
• Financing activities provided $23,498,646, mainly from the issuance of common stock.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing negatively due to continued net losses, a sharp decline in cash reserves, increased operating expenses, and significant internal control weaknesses, compounded by Nasdaq delisting concerns.

Positives

• Revenue increased by 15.2% to $1,524,262 in fiscal year 2025.
• Significant revenue growth in the wellness and wellbeing lifestyle segment (948.9%) and green energy segment (226.7%).
• Net loss decreased by 7.2% to $2,307,607 in fiscal year 2025.
• The company has a strong gross profit margin of 55.0% for FY2025.
• The company secured $23 million in proceeds from the issuance of common stock in 2025.

Negatives

• The company reported a net loss of $2,307,607 for the fiscal year ended December 31, 2025.
• Cash and cash equivalents decreased from $2,040,243 to $140,072.
• Operating expenses increased by 22.9% to $4,094,917.
• Revenue from the network marketing business decreased by 48.0%.
• Revenue from complementary health therapies decreased by 3.5%.
• The company has substantial accumulated deficits of $11,797,836 as of December 31, 2025.
• The company has identified material weaknesses in its internal control over financial reporting.

Risks

• Heavy reliance on two largest suppliers for product supply, with no long-term agreements.
• Potential for disruption in product supply due to labor disputes, natural disasters, or pandemics.
• Risk of changes in supplier sales or marketing strategies, including appointing competing distributors.
• Adverse impact from changes in consumer preferences, perceptions, and spending habits.
• Failure to develop or gain market acceptance for new products.
• Potential for product liability claims, product recalls, or adverse publicity.
• Susceptibility to food-borne illnesses and contamination of products.
• Intense competition in the health and wellness market in Malaysia.
• Potential delisting from Nasdaq due to low bid price.
• Inability to meet continued listing standards of Nasdaq.
• Lack of insurance coverage for operations could lead to significant costs and business disruption.
• Adverse effects from fluctuations in foreign currency exchange rates.
• Dependence on key executive officers, particularly the CEO, with no key man insurance.
• Potential dilution of shareholder equity through future financing efforts.
• The company has a limited operating history in the health and wellness industry, making future prospects difficult to evaluate.
• The company has a significant deposit of $23.8 million with Bi Cheng Investment Management Limited in the PRC, with associated credit risk and potential difficulties in repatriation.

Future Outlook

The company's future outlook is uncertain due to its net losses, decreasing cash reserves, and ongoing efforts to address material weaknesses in internal controls. The company's ability to continue as a going concern depends on its success in increasing revenue, controlling costs, generating positive cash flow, and securing external financing.

Management Comments

• The company is positioning itself for sustainable growth by diversifying its operations into the domain of renewable energy.
• The company believes the quality of the products coupled with the effectiveness of the distribution network have been the primary reasons for the success and will allow the Company to pursue future business expansion.
• The company is committed to providing our distributors with quality products to help them increase sales and recruit additional distributors.
• Management is responsible for establishing and maintaining adequate internal control over financial reporting.
• Management believes that the anticipated cash flows from operating activities together with cash on hand will be sufficient to meet our anticipated working capital requirements and capital expenditures in the ordinary course of business for the next twelve months.

Industry Context

StockSavvy.ai notes that Agape ATP Corporation operates in the health and wellness sector, a competitive market in Malaysia. The company's diversification into green energy reflects a broader industry trend towards sustainability. However, the company's financial performance, marked by net losses and a significant decrease in cash, alongside internal control issues and Nasdaq delisting concerns, presents considerable challenges.

Corporate Governance

Legal Proceedings

• The company knows of no material, active or pending legal proceedings against it, nor is it involved as a plaintiff in any material proceedings or pending litigation.

Related Party Transactions

• Purchases of products for complementary health therapies from CTA Nutriceuticals (Asia) Sdn Bhd totaled $365,840 in 2025.
• Office rental expenses from DSY Wellness & Longevity Center Sdn Bhd totaled $98,628 in 2025.
• IT support services fees from TH3 Holdings Sdn Bhd totaled $62,179 in 2025.
• Selling and event related expenses from Cedar Wellness Sdn Bhd totaled $51,254 in 2025.
• Mr. How Kok Choong, CEO, received $831,709 in salary, commission, and borrowings from the company in 2025.
• The company made prepayments of IT expenses to TH3 Holdings Sdn Bhd totaling $1,849 in 2025.
• The company made purchases of beauty products from SY Welltech Sdn Bhd totaling $1,157 in 2025.
• The company made purchases of products for general use from CTA Nutriceuticals (Asia) Sdn Bhd totaling $3,166 in 2025.

Stakeholder Impact

• Shareholders may experience dilution due to future equity issuances for capital raising.
• Shareholders face risks of share price volatility and potential delisting from Nasdaq.
• Distributors and customers may be impacted by product availability issues due to supplier reliance.
• Employees may be affected by the company's financial instability and efforts to address internal control weaknesses.

Next Steps

• The company plans to hire full-time personnel with appropriate accounting knowledge and experience.
• The company plans to establish a formal process for monthly book closing and transaction accounting.
• The company plans to engage a consulting firm to improve internal controls.
• The company intends to initiate a comprehensive training program for accounting staff.
• The company is working to regain compliance with Nasdaq's minimum bid price requirement by July 27, 2026.

Key Dates

Recommendation

The company's continued net losses, declining cash position, increased operating expenses, material weaknesses in internal controls, and Nasdaq delisting concerns present significant financial and operational risks. While revenue has grown, it is not sufficient to offset losses, and the company's ability to continue as a going concern is in doubt without further financing. The substantial deposit with a PRC-based investment manager adds another layer of risk. Therefore, a sell recommendation is warranted.

Keywords

Agape ATP Corporation, Form 10-K, Annual Report, Health and Wellness, Network Marketing, Green Energy, Financial Results, Revenue Growth, Net Loss, SEC Filing